198 related articles for article (PubMed ID: 25400747)
41. Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma.
Yoshida R; Morita M; Shoji F; Nakashima Y; Miura N; Yoshinaga K; Koga T; Tokunaga E; Saeki H; Oki E; Oda Y; Maehara Y
Ann Surg Oncol; 2015 Aug; 22(8):2608-14. PubMed ID: 25564163
[TBL] [Abstract][Full Text] [Related]
42. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
44. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
[TBL] [Abstract][Full Text] [Related]
45. VEGF-C: an indicator of lymph node metastasis for patients that underwent esophagectomy.
Wang X
Hepatogastroenterology; 2012 Oct; 59(119):2027-31. PubMed ID: 22626857
[TBL] [Abstract][Full Text] [Related]
46. Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.
Singhi AD; Seethala RR; Nason K; Foxwell TJ; Roche RL; McGrath KM; Levy RM; Luketich JD; Davison JM
Hum Pathol; 2015 Mar; 46(3):366-75. PubMed ID: 25582499
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
48. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
49. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Shamma A; Doki Y; Tsujinaka T; Shiozaki H; Inoue M; Yano M; Kawanishi K; Monden M
Oncology; 2000 Feb; 58(2):152-8. PubMed ID: 10705242
[TBL] [Abstract][Full Text] [Related]
50. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
52. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
[TBL] [Abstract][Full Text] [Related]
53. High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
Liu HX; Li N; Wei L; Zhou FX; Ma R; Xiao F; Zhang W; Zhang Y; Hui YP; Song H; Chen BL
Tumour Biol; 2017 Jun; 39(6):1010428317710225. PubMed ID: 28639905
[TBL] [Abstract][Full Text] [Related]
54. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
Deng F; Zhou K; Cui W; Liu D; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
[TBL] [Abstract][Full Text] [Related]
56. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
57. Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: correlation with DNA content.
El-Kenawy Ael-M; Lotfy M; El-Kott A; El-Shahat M
J Clin Gastroenterol; 2005 Oct; 39(9):791-4. PubMed ID: 16145342
[TBL] [Abstract][Full Text] [Related]
58. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.
Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS
Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639
[TBL] [Abstract][Full Text] [Related]
59. FOXP3 expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer.
Wang G; Liu G; Liu Y; Li X; Su Z
Hepatogastroenterology; 2012 Oct; 59(119):2186-91. PubMed ID: 22389297
[TBL] [Abstract][Full Text] [Related]
60. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
